Dan L.

Dan L. is a seasoned program consultant at Xperi Corporation since March 2021, bringing extensive experience in mergers and acquisitions, business compliance, and project management. Previously, Dan managed divestiture processes at Novartis, working closely with senior leadership and stakeholders globally. Dan's background includes compliance roles at Pharmacyclics and BBAM LLC, focusing on SOX controls, as well as senior management positions at Genentech and Cisco. Dan holds an MBA in Management and IT from the State University of New York and a BBA in Accounting and IT from Pace University.